Skip to main content

iwCLL 2023 Main banner

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Junji Suzumiya, MD, PhD

Vice-president
Department of Hematology, Koga Community Hospital, Japan

N/A

Poster(s):

1126 - Significance of sIL-2R and LD in predicting time to first treatment in Japanese CLL patients with early asymptomatic disease.